Assignee
CYTRX CORP
US·27 granted patents·5 pending applications·862 citations·filing 1993–2019
Top patents by PatentIndex Score
32 records- 0194US6416947B1Vaccine adjuvant and vaccine methodCYTRX CORP·Filed 2000·Granted Jul 9, 2002·45 cites·22 claims
- 0293US7691849B2Carboxamidine derivatives and their use in the treatment of vascular diseasesCYTRX CORP·Filed 2007·Granted Apr 6, 2010·14 cites·27 claims
- 0392US6747064B2Polyoxypropylene/polyoxyethylene copolymers with improved biological activityCYTRX CORP·Filed 2001·Granted Jun 8, 2004·29 cites·6 claims
- 0491US5691387APolyoxypropylene/polyoxyethylene copolmers with improved biological activityCYTRX CORP·Filed 1996·Granted Nov 25, 1997·43 cites·21 claims
- 0590US7550457B2Pharmaceutically effective compoundsCYTRX CORP·Filed 2007·Granted Jun 23, 2009·13 cites·19 claims
- 0690US5824322ACompositions and methods for growth promotionCYTRX CORP·Filed 1996·Granted Oct 20, 1998·107 cites·8 claims
- 0790US5523492APolyoxypropylene/polyoxyethylene copolymers with improved biological activityCYTRX CORP·Filed 1993·Granted Jun 4, 1996·72 cites·28 claims
- 0889US5696298APolyoxypropylene/polyoxyethylene copolymers with improved biological activityCYTRX CORP·Filed 1995·Granted Dec 9, 1997·99 cites·14 claims
- 0985US7148239B2Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereofCYTRX CORP·Filed 2003·Granted Dec 12, 2006·23 cites·34 claims
- 1083US7384936B2Carboxamidine derivatives and their use in the treatment of vascular diseasesCYTRX CORP·Filed 2003·Granted Jun 10, 2008·14 cites·10 claims
- 1182US7361655B2Pharmaceutically effective compoundsCYTRX CORP·Filed 2004·Granted Apr 22, 2008·13 cites·11 claims
- 1282US5990241APolyoxypropylene/polyoxyethylene copolymers with improved biological activityCYTRX CORP·Filed 1997·Granted Nov 23, 1999·39 cites·176 claims
- 1382US5567859APolyoxypropylene/polyoxyethylene copolymers with improved biological activityCYTRX CORP·Filed 1994·Granted Oct 22, 1996·66 cites·12 claims
- 1481US7126002B2Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compoundsCYTRX CORP·Filed 2001·Granted Oct 24, 2006·21 cites·5 claims
- 1580US7745465B2Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereofCYTRX CORP·Filed 2003·Granted Jun 29, 2010·13 cites·11 claims
- 1680US6359014B1Polyoxypropylene/polyoxyethylene copolymers with improved biological activityCYTRX CORP·Filed 1999·Granted Mar 19, 2002·21 cites·30 claims
- 1779US5674911AAntiinfective polyoxypropylene/polyoxyethylene copolymers and methods of useCYTRX CORP·Filed 1995·Granted Oct 7, 1997·55 cites·17 claims
- 1878US6086899AVaccine adjuvant and vaccineCYTRX CORP·Filed 1995·Granted Jul 11, 2000·22 cites·16 claims
- 1978USRE36665EPolyoxypropylene/polyoxyethylene copolymers with improved biological activityCYTRX CORP·Filed 1998·Granted Apr 18, 2000·31 cites·3 claims
- 2076US2009253690A1Pharmaceutically effective compoundsCYTRX CORP·Filed 2009·Application pending·0 cites
- 2167US10278981B2Cytotoxic agents for the treatment of cancerCYTRX CORP·Filed 2014·Granted May 7, 2019·1 cites·10 claims
- 2267US5407445AGel composition for implant prosthesis and method of useCYTRX CORP·Filed 1993·Granted Apr 18, 1995·72 cites·16 claims
- 2362US7045576B2Adjuvants and copolymer compositionsCYTRX CORP·Filed 2004·Granted May 16, 2006·3 cites·6 claims
- 2461USRE38558EPolyoxypropylene/polyoxyethylene copolymers with improved biological activityCYTRX CORP·Filed 1999·Granted Jul 20, 2004·22 cites·18 claims
- 2561USRE37285EPolyoxypropylene/polyoxyethylene copolmers with improved biological activityCYTRX CORP·Filed 1999·Granted Jul 17, 2001·13 cites·21 claims
- 2661US6149922AVaccine adjuvant and vaccineCYTRX CORP·Filed 1998·Granted Nov 21, 2000·11 cites·5 claims
- 2755US10881678B2Cytotoxic agents for the treatment of cancerCYTRX CORP·Filed 2019·Granted Jan 5, 2021·0 cites·9 claims
- 2850US2010267711A1Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereofCYTRX CORP·Filed 2010·Application pending·0 cites
- 2945US10328093B2Anthracycline formulationsCYTRX CORP·Filed 2017·Granted Jun 25, 2019·0 cites·39 claims
- 3045US2009227572A1Treatment of diabetic wounds and peripheral neuropathiesCYTRX CORP·Filed 2009·Application pending·0 cites
- 3143US2015342975A1Anthracycline formulationsCYTRX CORP·Filed 2013·Application pending·0 cites
- 3236US2007015720A1Modulation of endogenous AICAR levels for the treatment of diabetes and obesityCYTRX CORP·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CYTRX CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →